NANa An

Na An

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Na An has a total of 56 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Wenxin Granules Prevent Ibrutinib‐Associated Atrial Fibrillation Through Restoring Redox Balance and Calcium Homeostasis

    by Xinyu Yang, Hao Yang, Na An, Fan Yang, Linke Jiao, Donghua Yang, Jie Zhao, Yonghong Gao, Yanwei Xing, Hongcai Shang

    Background: Ibrutinib, a frontline therapy for chronic lymphocytic leukemia (CLL), has been associated with an approximately 10‐fold increased risk of atrial fibrillation (AF) during treatment. Wenxin Granules, as a multi‐component and multi‐target drug, exert therapeutic effects on AF. Methods: We conducted electrophysiological studies in ibrutinib‐treated mice models to assess AF inducibility and the therapeutic efficacy of Wenxin Granules. Through network pharmacology screening, we identified potential molecular targets of Wenxin Granules. Subsequent proteomic analysis revealed specific targets through which Wenxin Granules may prevent ibrutinib‐associated AF. These targets were further validated in mice model experiments. Results: Our study demonstrates that Wenxin Granules treatment in mice significantly reduces AF inducibility, shortens AF duration, and attenuates pathological cardiac remodeling, including left atrial (LA) enlargement and myocardial fibrosis ( p < 0.05). Through comprehensive analysis integrating proteomics with network pharmacology‐predicted molecular targets, we systematically screened and identified 25 core therapeutic targets of Wenxin Granules, which are primarily associated with oxidative stress and calcium protein‐related signaling pathways. The ibrutinib treatment group demonstrated significantly elevated expression of reactive oxygen species (ROS)‐related proteins, including NOX2, NOX4, p22‐phox, and XO. Additionally, ibrutinib substantially increased the expression of ox‐CaMKII, p‐CaMKII (Thr‐286), and p‐RyR2 (Ser2814), resulting in enhanced abnormal sarcoplasmic reticulum (SR) Ca 2+ release, altered mitochondrial structures, and atrial fibrosis. Notably, Wenxin Granules administration reduced the expression of these proteins ( p < 0.05). Conclusions: These findings demonstrate that Wenxin Granules can ameliorate the occurrence and progression of AF induced by ibrutinib treatment, thereby laying the groundwork for further research and potential clinical applications in AF therapy.

  • Berberine Ameliorates Atrial Remodeling and Inhibits the Atrial Fibrillation of Mice via Regulating NLRP3 Inflammasome

    by Na An, Fan Yang, Nian Liu, Yonghong Gao, Hongcai Shang, Yanwei Xing

    Increased cardiomyocyte‐specific activation of the NLRP3 inflammasome contributes to the development of atrial fibrillation (AF). Berberine (BBR) exhibits numerous beneficial effects on the cardiovascular system. This study investigated how the NLRP3 inflammasome regulates susceptibility to hypertension‐induced AF and the effects of BBR on this susceptibility. Blood pressure was monitored in mice using a tail pressure sensor device. AF was induced by burst stimulation of the esophagus. The target proteins of BBR were screened by network pharmacology, and molecular docking was performed. The changes in atrial tissue structure were observed by pathological tissue staining and transmission electron microscopy. Western blot analysis was used for protein verification. Intracellular Ca2+ release was detected by confocal laser microscopy and the IonOptix system. We found that in angiotensin II (Ang II)‐induced AF, NLRP3 inflammasome activation was inhibited, ultimately inhibiting hypertensive AF susceptibility. In a recombinant adeno‐associated virus 9 (rAAV9)‐NLRP3 overexpression model, BBR mitigated the increase in systolic blood pressure and the development and progression of AF by inhibiting the NLRP3 inflammasome. This study provides hitherto undocumented evidence that the NLRP3 inflammasome acts as a critical regulator in the progression of Ang II‐induced AF and that BBR may serve as a viable treatment for AF by inhibiting NLRP3.


  • The role and mechanism of TXNDC5 in cardio-oncology: Killing two birds with one stone?

    by Na An, Xiaoyu Zhang, Hongyuan Lin, Qianqian Xu, Qianqian Dai, YiFan Kong, Songjie Han, Xiao Li, Xinyu Yang, Yanwei Xing, et al.


  • Open Access

    Understanding the Protective Role of Exosomes in Doxorubicin‐Induced Cardiotoxicity

    by Guoxia Zhang, Xinyu Yang, Xin Su, Na An, Fan Yang, Xinye Li, Yuchen Jiang, Yanwei Xing

    Doxorubicin (DOX) is a class of effective chemotherapeutic agents widely used in clinical practice. However, its use has been limited by cardiotoxicity. The mechanism of DOX‐induced cardiotoxicity (DIC) is complex, involving oxidative stress, Ca2+ overload, inflammation, pyroptosis, ferroptosis, apoptosis, senescence, etc. Exosomes (EXOs), as extracellular vesicles (EVs), play an important role in the material exchange and signal transmission between cells by carrying components such as proteins and RNAs. More recently, there has been a growing number of publications focusing on the protective effect of EXOs on DIC. Here, this review summarized the main mechanisms of DIC, discussed the mechanism of EXOs in the treatment of DIC, and further explored the value of EXOs as diagnostic biomarkers and therapeutic strategies for DIC.


  • Open Access

    Network Pharmacology and Bioinformatics Methods Reveal the Mechanism of Berberine in the Treatment of Ischaemic Stroke

    by Ke Song, Yikun Sun, Haoqi Liu, Yuanyuan Li, Na An, Liqin Wang, Hanlai Zhang, Fan Yang, Yanwei Xing, Yonghong Gao

    Aim. To elucidate the mechanism of action of berberine on ischaemic stroke based on network pharmacology, bioinformatics, and experimental verification. Methods. Berberine-related long noncoding RNAs (lncRNAs) were screened from public databases. Differentially expressed lncRNAs in ischaemic stroke were retrieved from the Gene Expression Omnibus (GEO) database. GSE102541 was comprehensively analysed using GEO2R. The correlation between lncRNAs and ischaemic stroke was evaluated by the mammalian noncoding RNA-disease repository (MNDR) database. The component-target-disease network and protein-protein interaction (PPI) network of berberine in the treatment of ischaemic stroke were constructed by using network pharmacology. We then performed gene ontology (GO) and Kyoto Encyclopaedia of Genes and Genomes (KEGG) enrichment analyses. Finally, according to the molecular docking analysis and the binding probability between the lncRNA and key proteins, the effectiveness of the results was further verified by in vitro experiments. Results. After matching stroke-related lncRNAs with berberine-related lncRNAs, four genes were selected as potential targets of berberine in the treatment of ischaemic stroke. Subsequently, lncRNA H19 was identified as the potential crucial regulatory lncRNA of berberine. Here, 52 target proteins of berberine in the treatment of ischaemic stroke were identified through database mining. Through topological analysis, 20 key targets were identified which were enriched in inflammation, apoptosis, and immunity. Molecular docking results showed that MAPK8, JUN, and EGFR were central genes. Finally, in vitro experiments demonstrated that lncRNA H19, p-JNK1/JNK1, p-c-Jun/c-Jun, and EGFR expressions were significantly increased in hypoxia-treated SH-SY5Y cells and were restored by berberine treatment. Conclusion. The potential targets and biological effects of berberine in the treatment of ischaemic stroke were predicted in this study. The lncRNA H19/EGFR/JNK1/c-Jun signalling pathway may be a key mechanism of berberine-induced neuroprotection in ischaemic stroke.


  • Open Access

    Mitochondrial Damage in Myocardial Ischemia/Reperfusion Injury and Application of Natural Plant Products

    by Xin Su, Mingyang Zhou, Yingjian Li, Na An, Fan Yang, Guoxia Zhang, Lianjiang Xu, Hengwen Chen, Hongjin Wu, Yanwei Xing

    Ischemic heart disease (IHD) is currently one of the leading causes of death among cardiovascular diseases worldwide. In addition, blood reflow and reperfusion paradoxically also lead to further death of cardiomyocytes and increase the infarct size. Multiple evidences indicated that mitochondrial function and structural disorders were the basic driving force of IHD. We summed up the latest evidence of the basic associations and underlying mechanisms of mitochondrial damage in the event of ischemia/reperfusion (I/R) injury. This review then reviewed natural plant products (NPPs) which have been demonstrated to mitochondria‐targeted therapeutic effects during I/R injury and the potential pathways involved. We realized that NPPs mainly maintained the integrality of mitochondria membrane and ameliorated dysfunction, such as improving abnormal mitochondrial calcium handling and inhibiting oxidative stress, so as to protect cardiomyocytes during I/R injury. This information will improve our knowledge of mitochondrial biology and I/R‐induced injury’s pathogenesis and exhibit that NPPs hold promise for translation into potential therapies that target mitochondria.


  • Open Access

    Tai Chi as a Therapy of Traditional Chinese Medicine on Reducing Blood Pressure: A Systematic Review of Randomized Controlled Trials

    by Xiandu Pan, Li Tian, Fan Yang, Jiahao Sun, Xinye Li, Na An, Yanfen Xing, Xin Su, Xu Liu, Can Liu, et al.

    Objective. This study systematically evaluated the effects of Tai Chi exercise on blood pressure, body mass index (BMI), and quality of life (QOL) in patients with hypertension. A meta-analysis was performed to provide a reliable reference for clinical practice. Methods. We searched for randomized controlled trials (RCTs) in five English databases and two Chinese databases, with the earliest data dated December 5, 2020. A quality assessment of the methods and a meta-analysis were also conducted. Results. The meta-analysis of 24 studies showed that the intervention group showed better outcomes in terms of systolic blood pressure (SBP) (SMD −1.05, 95% CI −1.44 to −0.67, ; I2 = 93.7%), diastolic blood pressure (DBP) (SMD −0.91, 95% CI −1.24 to −0.58, ; I2 = 91.9%), and QOL (physical functioning (SMD 0.86, 95% CI 0.36 to 1.37, ; I2 = 91.3%), role-physical (SMD 0.86, 95% CI 0.61 to 1.11, ; I2 = 65%), general health (SMD 0.75, 95% CI 0.32 to 1.17, ; I2 = 88.1%), bodily pain (SMD 0.65, 95% CI 0.29 to 1.00, ; I2 = 83.1%), vitality (SMD 0.71, 95% CI 0.34 to 1.07, ; I2 = 84.3%), social functioning (SMD 0.63, 95% CI 0.07 to 1.19, ; I2 = 93.1%), role-emotional (SMD 0.64, 95% CI 0.22 to 1.06, ; I2 = 88.1%), and mental health (SMD 0.73, 95% CI 0.31 to 1.16, ; I2 = 88.2%)) compared to those of the control group. However, no significant improvements were seen in BMI of the intervention group (SMD −0.08, 95% CI −0.35 to −0.19, ; I2 = 69.4%) compared to that of the control group. Conclusion. Tai Chi is an effective intervention to improve SBP and DBP in patients with essential hypertension.


  • Open Access

    Targeting Ferroptosis: Pathological Mechanism and Treatment of Ischemia‐Reperfusion Injury

    by Xinye Li, Ning Ma, Juping Xu, Yanchi Zhang, Pan Yang, Xin Su, Yanfeng Xing, Na An, Fan Yang, Guoxia Zhang, et al.

    Ischemia‐reperfusion (I/R) is a pathological process that occurs in many organs and diseases. Reperfusion, recovery of blood flow, and reoxygenation often lead to reperfusion injury. Drug therapy and early reperfusion therapy can reduce tissue injury and cell necrosis caused by ischemia, leading to irreversible I/R injury. Ferroptosis was clearly defined in 2012 as a newly discovered iron‐dependent, peroxide‐driven, nonapoptotic form of regulated cell death. Ferroptosis is considered the cause of reperfusion injury. This discovery provides new avenues for the recognition and treatment of diseases. Ferroptosis is a key factor that leads to I/R injury and organ failure. Given the important role of ferroptosis in I/R injury, there is considerable interest in the potential role of ferroptosis as a targeted treatment for a wide range of I/R injury‐related diseases. Recently, substantial progress has been made in applying ferroptosis to I/R injury in various organs and diseases. The development of ferroptosis regulators is expected to provide new opportunities for the treatment of I/R injury. Herein, we analytically review the pathological mechanism and targeted treatment of ferroptosis in I/R and related diseases from the perspectives of myocardial I/R injury, cerebral I/R injury, and ischemic renal injury.


  • Open Access

    Urinary Nickel Ion Evaluation of Adolescents during the Initial Period of Orthodontic Fixed Treatment

    by Yongjuan Guo, Yi Liu, Ying Zheng, Na An, Lu Bai

    Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies